Winton Matthew
Insider CIK 1971400 · CRVO Chief Commercial and Business · INZY COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRVO CervoMed Inc. | A Award deriv | 2026-10-22 | 2026-10-23 | 19,100 | — | $0 | 19,100 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2026-02-11 | 2026-02-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CRVO CervoMed Inc. | P Buy | 2025-11-18 | 2025-11-19 | 1,500 | $7.95 | $11.9K | 15,000 | SEC↗ |
| CRVO CervoMed Inc. | P Buy | 2025-11-17 | 2025-11-19 | 3,500 | $8.43 | $29.5K | 13,500 | SEC↗ |
| CRVO CervoMed Inc. | P Buy | 2025-11-14 | 2025-11-17 | 10,000 | $7.57 | $75.7K | 10,000 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2025-10-06 | 2025-10-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 145,000 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 41,500 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | U Tender | 2025-07-01 | 2025-07-03 | 21,743 | $4.00 | $87.0K | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2025-06-25 | 2025-06-27 | 14,355 | $0.74 | $10.6K | 21,743 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2025-03-31 | 2025-04-02 | 2,490 | $0.77 | $1.9K | 7,388 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2025-03-11 | 2025-03-17 | 145,000 | — | $0 | 145,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2025-03-11 | 2025-03-17 | 41,500 | — | $0 | 41,500 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2024-09-30 | 2024-10-03 | 1,710 | $4.45 | $7.6K | 4,898 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2024-03-28 | 2024-04-03 | 3,188 | $3.33 | $10.6K | 3,188 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2024-03-13 | 2024-03-15 | 175,000 | — | $0 | 175,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2023-04-03 | 2023-04-04 | 250,000 | — | $0 | 250,000 | SEC↗ |